The FDA is launching a pilot program using AI and cloud computing to monitor clinical trials in real time. The agency expects the initiative to accelerate drug approval timelines.
The FDA's new monitoring system leverages artificial intelligence and cloud infrastructure to track clinical trial data as it emerges, rather than relying on traditional post-trial analysis.
Real-time oversight could identify safety issues and efficacy signals earlier in the trial process, potentially shortening the overall approval timeline for new drugs. The pilot program represents a significant operational shift for the agency.
This development comes as the FDA rebuilds its workforce following staffing reductions tied to DOGE (Department of Government Efficiency) initiatives. The agency is positioning automation and advanced technologies as force multipliers to maintain oversight capabilities amid staffing constraints.
Cloud-based systems and AI analytics allow remote monitoring of distributed trial sites and participant data, reducing the manual review burden on FDA staff. The pilot will test whether these tools deliver on their promised efficiency gains while maintaining regulatory rigor.
The program underscores a broader trend across federal agencies toward adopting AI and cloud solutions to modernize operations and improve service delivery.
Israel-based Hemispheric secured $52 million in funding for its AI model that analyzes non-invasive brain activity measurements and converts them into quantitative diagnostic metrics.
Anthropic and Blackstone are backing Ode, a new venture that embeds AI engineers directly inside enterprises. The bet signals a shift in where the next trillion dollars in AI value may be created: not in building models, but in implementing them.
Spectro Cloud, an AI infrastructure company focused on managing token costs, secured $100 million in Series D funding at a valuation exceeding $1 billion. The raise marks significant growth from the company's $750 million valuation in 2024.
Startups like Altur are deploying AI chatbots to handle debt collection calls, automating a process traditionally done by humans. Y Combinator has backed six debt collection and settlement startups over the past six years.